
A Michigan NP collaborative practice agreement must include specific elements in the physician’s written authorization when delegating controlled substance prescribing. It must list the supervising physician’s and APRN’s names, license numbers, signatures, any limitations or exceptions to the delegation, and the effective date1. The physician must review and update the authorization annually and note each review date; it must be kept at the physician’s primary practice location and a copy provided to the APRN23.
When controlled substances are prescribed under a written authorization, both the APRN’s and the physician’s names and DEA registration numbers must be used or recorded with the prescription4. The delegating physician may authorize multiple prescriptions totaling up to a 90-day supply of a Schedule II controlled substance, but may not delegate prescribing intended to cause miscarriage or fetal death in a patient known to be pregnant56.
Note that APRNs may independently prescribe nonscheduled (non-controlled) medications without physician delegation, while complimentary starter doses of controlled substances require delegation and must reflect both parties’ identifiers78. Michigan law does not specify meeting or maximum-supervisee requirements for such authorizations, but defines supervision to include continuous communication availability, periodic review, and predetermined procedures and drug protocols9.